Alzheimer's drug aducanumab not approved for use in EU

Alzheimer's drug aducanumab not approved for use in EU
Charities are disappointed but regulators say there is still little evidence of the drug's benefit.
Image source, Getty Images The European Medicines Agency has said no to approving a new drug for Alzheimer's disease in the EU. Aducanumab does not appear to be effective at treating adults with ea… [+1878 chars] Read More



Related Stories

See All